Add to ORKGSublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II stud
Over 90% of patients treated for head and neck cancer with curatively aimed chemo or bioradiotherapy...
Enno FreyeCenter of Ambulatory Pain Medicine, Neuss-Uedesheim, GermanyAbstract: Breakthrough pain, a...
Breakthrough pain has been recognized as a challenging pain phenomenon in cancer. Oral transmucosal ...
Donald R Taylor Comprehensive Pain Care PC, Marietta, GA, USA Abstract: Breakthrough cancer pain (BT...
The Author(s) 2013. This article is published with open access at Springerlink.com Breakthrough pain...
Aim: This subanalysis of the CAVIDIOPAL study evaluated the impact of individualized management of b...
Objective: The aim of this study was to prospectively assess the efficacy and safety of low doses of...
Aim: To investigate the relationship between effective fentanyl sublingual spray (FSS) doses for bre...
Aim: This subanalysis of the CAVIDIOPAL study evaluated the impact of individualized management of b...
Abstract OBJECTIVE: The aim of this study was to prospectively assess the efficacy and safety of s...
The management of cancer pain presents manifold challenges: Even though background pain is adequatel...
Context: Breakthrough cancer pain (BTcP) is widely recognized as a clinically significant complicati...
Breakthrough pain (BTP) is a transitory flare of pain superimposed on an otherwise stable pain patte...
AbstractContextBreakthrough cancer pain (BTcP) is widely recognized as a clinically significant comp...
Purpose Fentanyl sublingual tablets (FST) are a potentially useful alternative to parenteral opioids...
Over 90% of patients treated for head and neck cancer with curatively aimed chemo or bioradiotherapy...
Enno FreyeCenter of Ambulatory Pain Medicine, Neuss-Uedesheim, GermanyAbstract: Breakthrough pain, a...
Breakthrough pain has been recognized as a challenging pain phenomenon in cancer. Oral transmucosal ...
Donald R Taylor Comprehensive Pain Care PC, Marietta, GA, USA Abstract: Breakthrough cancer pain (BT...
The Author(s) 2013. This article is published with open access at Springerlink.com Breakthrough pain...
Aim: This subanalysis of the CAVIDIOPAL study evaluated the impact of individualized management of b...
Objective: The aim of this study was to prospectively assess the efficacy and safety of low doses of...
Aim: To investigate the relationship between effective fentanyl sublingual spray (FSS) doses for bre...
Aim: This subanalysis of the CAVIDIOPAL study evaluated the impact of individualized management of b...
Abstract OBJECTIVE: The aim of this study was to prospectively assess the efficacy and safety of s...
The management of cancer pain presents manifold challenges: Even though background pain is adequatel...
Context: Breakthrough cancer pain (BTcP) is widely recognized as a clinically significant complicati...
Breakthrough pain (BTP) is a transitory flare of pain superimposed on an otherwise stable pain patte...
AbstractContextBreakthrough cancer pain (BTcP) is widely recognized as a clinically significant comp...
Purpose Fentanyl sublingual tablets (FST) are a potentially useful alternative to parenteral opioids...
Over 90% of patients treated for head and neck cancer with curatively aimed chemo or bioradiotherapy...
Enno FreyeCenter of Ambulatory Pain Medicine, Neuss-Uedesheim, GermanyAbstract: Breakthrough pain, a...
Breakthrough pain has been recognized as a challenging pain phenomenon in cancer. Oral transmucosal ...